Veradermics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -27,232 | -21,315 | |
Net Income | -27,232 | -21,847 | -12,400 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -21,168 | -23,633 | -13,336 |
Cash | 168,412 | 21,766 | |
Basic Shares | 37,340 | 37,340 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -69,995 | -25,903 | -16,454 |
Net Income | -69,995 | -26,488 | -16,489 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -71,626 | -23,688 | -13,510 |
Cash | 21,766 | 53,084 | 16,296 |
Basic Shares | 35,077 | 201,334 | 201,334 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.72 |
2025-12-31 | -$104.54 |